New pill shows promise for Hard-to-Treat cancers

NCT ID NCT03556228

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an experimental drug called VMD-928, taken as a pill, either alone or with another cancer drug (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have not responded to or are no longer controlled by available treatments. The goal is to check safety, find the best dose, and see if it can shrink tumors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

VMD-928 (a pill) and pembrolizumab (an immunotherapy drug)

What this could lead to

If successful, this could provide a new treatment option for people with certain advanced cancers that have stopped responding to other therapies.

What could go wrong

This is an early-phase trial with a small number of participants, so the drug may not prove effective or may cause significant side effects. It is not a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenoid cystic carcinoma esophageal cancer Esophageal Neoplasms head and neck cancer head and neck carcinoma Head and Neck Neoplasms head and neck squamous cell carcinoma hypopharynx cancer laryngeal disorder larynx cancer lip cancer lung cancer lung neoplasm malignant pancreatic neoplasm malignant tumor of nasopharynx mesothelioma nasopharyngeal carcinoma Neoplasm Metastasis non-small cell lung carcinoma NTRK fusion positive cancer oral cavity cancer oropharynx cancer pancreatic neoplasm salivary gland cancer salivary gland carcinoma small cell lung carcinoma Squamous Cell Carcinoma of Head and Neck tonsil cancer tracheal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Atlantic Health System, Morristown Medical Center (site 124)

    RECRUITING

    Morristown, New Jersey, 07962, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cancer Care Associates of York (site 206)

    RECRUITING

    York, Pennsylvania, 17403, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Englewood Hospital and Medical Center (site 202)

    RECRUITING

    Englewood, New Jersey, 07631, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hartford Hospital (site 210)

    RECRUITING

    Hartford, Connecticut, 06102, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Holy Cross Hospital (site 213)

    RECRUITING

    Fort Lauderdale, Florida, 33308, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Memorial Cancer Institute at Memorial Healthcare Systems (site 132)

    RECRUITING

    Pembroke Pines, Florida, 33028, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • PanOncology Trials, Hospital Oncologico - Puerto Rico Medical Center, Río Piedras (site 200)

    RECRUITING

    San Juan, 00935, Puerto Rico

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Presbyterian Kaseman Hospital (site 208)

    RECRUITING

    Albuquerque, New Mexico, 87110, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Providence Medical Foundation (site 209)

    RECRUITING

    Santa Rosa, California, 95403, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Summit Medical Group (site 205)

    RECRUITING

    Florham Park, New Jersey, 07932, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taylor Cancer Research Center (site 204)

    RECRUITING

    Maumee, Ohio, 43537, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The George Washington University Cancer Center (site 212)

    RECRUITING

    Washington D.C., District of Columbia, 20037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The University of Texas MD Anderson Cancer Center (site 127)

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Utah Cancer Specialists (site 203)

    RECRUITING

    Salt Lake City, Utah, 84106, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Weill Cornell Medicine, Cornell University (site 126)

    RECRUITING

    New York, New York, 10065, United States

    Contact

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••